AK Medical Holdings (HKSE:01789) EBIT : HK$254 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is AK Medical Holdings EBIT?

AK Medical Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$80 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$254 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. AK Medical Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was 4.64%. AK Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 12.82%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. AK Medical Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.72%.

AK Medical Holdings EBIT Historical Data

The historical data trend for AK Medical Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AK Medical Holdings EBIT Chart

AK Medical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

358.38

447.96

134.90

270.76

254.20

AK Medical Holdings Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial													-26.78	176.54	102.58	173.75	80.45

Competitive Comparison of AK Medical Holdings's EBIT

For the Medical Devices subindustry, AK Medical Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AK Medical Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AK Medical Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AK Medical Holdings's EV-to-EBIT falls into.

AK Medical Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$254 Mil.

AK Medical Holdings (HKSE:01789) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

AK Medical Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	148.258 * ( 1 - 32.27% )	/	( (2150.9	+	2177.43)	/ 2 )
=	100.4151434	/	2164.165
=	4.64 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3390.477	-	330.655	-	( 908.922	-	max(0, 699.544	-	2326.787	+	908.922	))
=	2150.9

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3284.644	-	312.396	-	( 794.818	-	max(0, 544.891	-	2160.012	+	794.818	))
=	2177.43

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

AK Medical Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	160.9	/	( ( (564.594 + max(637.77, 0))	+	(556.838 + max(751.395, 0)) )	/	2 )
=	160.9	/	( ( 1202.364	+	1308.233 )	/	2 )
=	160.9	/	1255.2985
=	12.82 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(654.868	+	589.386	+	63.91)	-	(330.655	+	0	+	339.739)
=	637.77

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(493.733	+	651.361	+	112.217)	-	(312.396	+	0	+	193.52)
=	751.395

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

AK Medical Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	254.199	/	5386.118
	=	4.72 %

AK Medical Holdings EBIT Related Terms

Thank you for viewing the detailed overview of AK Medical Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

AK Medical Holdings (HKSE:01789) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AK Medical Holdings Ltd (HKSE:01789) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10 Baifuquan Road, 2nd Floor, Xingye Mansion, Changping District Science and Technology Park, Beijing, CHN, 102200

Website

https://www.ak-medical.net/index.html

AK Medical Holdings Ltd is an investment holding company which designs, develops, produces, and markets orthopedic joint implants and related products. The company's geographical segments include China and the United Kingdom. It derives the majority of revenue from China. The company offers off-the-shelf products, such as knee replacement and hip replacement implants; and 3D-printed products, including 3D-printed hip replacement implants, spinal interbody cages, and artificial vertebral bodies.

AK Medical Holdings (HKSE:01789) Headlines

No Headlines